Remote Access to Care, Everywhere, for Parkinson Disease

University of Rochester277 enrolled

Overview

The primary objective of this study is to evaluate the feasibility, efficacy and the value of providing care to individuals with Parkinson disease directly into their homes. The specific aims are: 1. To demonstrate the feasibility of conducting remote evaluations of patients with Parkinson disease nationally; 2. To measure the impact of remote care on each patient's ability to improve his or her quality of life (QoL) and better manage his or her Parkinson disease; and 3. To assess the long-term acceptability to patients in receiving ongoing care remotely via telemedicine.

Study Type

INTERVENTIONAL

Allocation

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

277

Conditions

Parkinson Disease

Interventions

Virtual care visitOTHER

Video-conferencing visit with a Parkinson disease specialist

Eligibility

Sex: ALLMin age: 30 YearsMax age: 120 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age greater than 30 * Self reported diagnosis of idiopathic Parkinson disease * Ability to converse in English * Ability and willingness to provide informed consent and complete study requirements * Access to a non-public computer or similar devices with broadband internet. * Located in New York, Maryland, Delaware, California, or Florida at time of virtual visit (or veterans with Parkinson disease anywhere in the U.S.) Exclusion Criteria: * Any condition (e.g.prominent psychosis) that in the investigator's or coordinator's judgment would preclude participation. * Concurrent enrollment in another telemedicine study.

Locations (3)

University of California San Francisco/San Francisco VA Medical Center

San Francisco, California, United States

University of Florida

Gainesville, Florida, United States

University of Rochester Medical Center

Rochester, New York, United States

Outcomes

Primary Outcomes

Feasibility

The percent of telemedicine visits completed as scheduled. (Goal \>80%)

Time frame: 6 months

Change in Quality of Life as Measured by the PDQ-39 Assessment Tool

The impact on Quality of life (QoL) as measured by the change in PDQ-39 score from baseline to 6 months. The PDQ-39 is a 39-item self-report questionnaire, which assesses Parkinson's disease-specific health related quality over the last month. 5-point ordinal scoring system: 0 = never, 1 = occasionally, 2 = sometimes, 3 = often, 4 = always. Each dimension total score range from 0 (never have difficulty) to 100 (always have difficulty). Lower scores reflect better quality of life.

Time frame: Baseline and 6 months

Secondary Outcomes

Acceptability

\- The percent of patients participated who stated that they are interested in receiving ongoing care for their PD via telemedicine. (Goal \>80%)

Time frame: 6 months

Feasibility (Descriptive)

Percentage of physician visits where the physician was were satisfied or very satisfied with the virtual visit overall.

Time frame: 6 months

Percentage of Patients Who Felt That the Recommendations Improved Their Health

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.